Evidence map›Paper›PMID 33260961›Full record

ArticleGenes2020

The Reversion of cg05575921 Methylation in Smoking Cessation: A Potential Tool for Incentivizing Healthy Aging.

Robert Philibert, James A Mills, Jeffrey D Long, Sue Ellen Salisbury, Alejandro Comellas, Alicia Gerke, Kelsey Dawes, Mark Vander Weg, Eric A Hoffman

Open access · goldAbstract read
In one paragraph

Article in Genes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Epigenetic biomarkers for smoking cessation.Addiction neuroscience · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. AhRR methylation contributes to disease progression in urothelial bladder cancer.Cancer biomarkers : section A of Disease markers · 2022
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Robert PhilibertDepartment of Psychiatry, University of Iowa, Iowa City, IA 52242, USA.
James A MillsDepartment of Psychiatry, University of Iowa, Iowa City, IA 52242, USA.
Jeffrey D LongDepartment of Psychiatry, University of Iowa, Iowa City, IA 52242, USA.ORCID 0000-0001-7181-9652
Sue Ellen SalisburyDepartment of Radiology, University of Iowa, Iowa City, IA 52242, USA.
Alejandro ComellasDepartment of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA.
Alicia GerkeDepartment of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA.
Kelsey DawesDepartment of Psychiatry, University of Iowa, Iowa City, IA 52242, USA.ORCID 0000-0003-4112-2760
Mark Vander WegDepartment of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA.ORCID 0000-0003-3631-0812
Eric A HoffmanDepartment of Radiology, University of Iowa, Iowa City, IA 52242, USA.
University of Iowa · US

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Brandi Janssen · 1990 to 2026
$40.5M
Functional CT Assessment of Pulmonary Arterial Dysfunction in Smoking Associated EmphysemaR01HL130883 · NHLBI · UNIVERSITY OF IOWA · PI HOFFMAN, ERIC ALFRED · 2016 to 2020
$3.6M
A Quantitative Epigenetic Test for Guiding Smoking Cessation TherapyR44CA213507 · NCI · BD HOLDING, INC. · PI PHILIBERT, ROBERT A · 2016 to 2017
$1.3M
NCI NIH HHS R44 CA213507NHLBI NIH HHS R01 HL130883NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

Smoking is the largest preventable cause of mortality and the largest environmental driver of epigenetic aging. Contingency management-based strategies can be used to treat smoking but require objective methods of verifying quitting status. Prior studies have suggested that cg05575921 methylation reverts as a function of smoking cessation, but that it can be used to verify the success of smoking cessation has not been unequivocally demonstrated. To test whether methylation can be used to verify cessation, we determined monthly cg05575921 levels in a group of 67 self-reported smokers undergoing biochemically monitored contingency management-based smoking cessation therapy, as part of a lung imaging protocol. A total of 20 subjects in this protocol completed three months of cotinine verified smoking cessation. In these 20 quitters, the reversion of cg05575921 methylation was dependent on their initial smoking intensity, with methylation levels in the heaviest smokers reverting to an average of 0.12% per day over the 3-month treatment period. In addition, we found suggestive evidence that some individuals may have embellished their smoking history to gain entry to the study. Given the prominent effect of smoking on longevity, we conclude that DNA methylation may be a useful tool for guiding and incentivizing contingency management-based approaches for smoking cessation.

Indexed as

DNA MethylationMotivationSmoking CessationAdultBasic Helix-Loop-Helix ProteinsBiomarkersCigarette SmokingClinical Trials as TopicCotinineCpG IslandsEthnicityEvidence-Based PracticeFemaleFollow-Up StudiesHealthy AgingHumansAHRR protein, humanBasic Helix-Loop-Helix ProteinsBiomarkersCotinineRepressor ProteinsAHRRcg05575921contingency managementDNA methylationsmoking cessation

Identifiers

PMID33260961
PMCPMC7760261
OpenAlexW3110228956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.